MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
about
"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.Chitosan Wound Dressings Incorporating Exosomes Derived from MicroRNA-126-Overexpressing Synovium Mesenchymal Stem Cells Provide Sustained Release of Exosomes and Heal Full-Thickness Skin Defects in a Diabetic Rat ModelA Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy agingInsights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications.Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo.MiR-126 Affects Brain-Heart Interaction after Cerebral Ischemic Stroke.Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review.Circulating MicroRNAs in Elderly Type 2 Diabetic Patients.
P2860
Q26747251-278D2BE4-19D4-49CF-BCC5-5DA5971FB788Q28079163-ADE98C7B-471C-4061-B037-2A39D5849805Q33720085-2B64C340-6F65-4672-8E6F-9C901DBB43C9Q33722397-EC229604-7833-4518-A509-D6827BFDD455Q37728970-A53280F1-0F03-4627-AEB4-E17BB60ABE32Q38430526-87978DE2-5E21-4014-9FC3-9A24FBF5AF25Q39041861-A15E2937-76C2-4295-B424-8A1DB3EE47B9Q41660553-5730E3DB-0A9B-45AE-8680-FAD2E0C9009FQ47100300-46F11742-1371-4DD1-9F5E-C680435A309EQ48336958-AEC3957C-F81F-4AD3-8D02-1A691E32C87CQ49748248-BA665C95-2123-4AC0-A369-7B2B31C5C4EDQ52608599-FEE8AF40-AB47-4075-B92D-094763450C6FQ55000266-9F01D52C-C9B4-4B77-8311-465579F9CF7D
P2860
MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@ast
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@en
type
label
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@ast
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@en
prefLabel
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@ast
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications.
@en
P2093
P2860
P50
P356
P1433
P1476
MiR-21-5p and miR-126a-3p leve ...... type 2 diabetes complications
@en
P2093
Antonio Domenico Procopio
Emanuela Mensà
Gabriele Santini
Liana Spazzafumo
Luigina Micolucci
Massimiliano Bonafè
Massimo Boemi
Mirko Gobbi
Raffaella Lazzarini
Roberto Testa
P2860
P304
35372-35382
P356
10.18632/ONCOTARGET.6164
P407
P50
P577
2015-11-01T00:00:00Z